Chronic arterial insufficiency of the lower limbs is characterized by intermittent claudication often localized to the calf. These early clinical symptoms are the results of the atherosclerotic process of the vasculature of the lower extremities. The treatment is aimed at reducing or eliminating the ischemic pain and at preventing progression of the atherosclerotic disease. Whether surgical or nonsurgical measures are used, the cornerstone of patient care lies in correction of the risk factors. Smoking cessation and exercise therapy remain the fundamental measures in medical treatment of intermittent claudication. percutaneous transluminal angioplasty is an appropriate therapeutic option under certain criteria, especially for the iliac arte...
For patients with ischemic limb loss, the treatment of choice is revascularization with the aim of s...
Luigi Uccioli,1 Marco Meloni,1 Valentina Izzo,1 Laura Giurato,1 Stefano Merolla,2 Roberto Gandini2 1...
Recommendations stated in the TASC II guidelines for the treatment of peripheral arterial disease (P...
Chronic arterial insufficiency of the lower limbs is characterized by intermittent claudication ofte...
Atherosclerosis affects large elastic and muscular arteries, the most commonly and severely affected...
The mainstay of therapy for peripheral arterial disease (PAD) consists ofatherosclerotic risk-factor...
Atherosclerosis of the lower limb arteries is the cause of ischemia in their area. Improper supply ...
Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an increasing ...
Intermittent claudication, according to the Fontaine Classification Scale is a symptom of 2nd degree...
Percutaneous intervention for peripheral artery disease hasevolved from balloon angioplasty for simp...
The treatment of intermittent claudication by physical re-training of a patient with lower limb arte...
Endovascular treatments of peripheral artery disease: revascularization techniques for patients pres...
Intermittent claudication is an expression of arteriosclerosis, in which pain occurs in the legs dur...
Peripheral arterial disease (PAD) comprises those entities which result in obstruction to blood flow...
A therosclerosis is the cause of the vast majority of cases ^*-of chronic peripheral arterial occlus...
For patients with ischemic limb loss, the treatment of choice is revascularization with the aim of s...
Luigi Uccioli,1 Marco Meloni,1 Valentina Izzo,1 Laura Giurato,1 Stefano Merolla,2 Roberto Gandini2 1...
Recommendations stated in the TASC II guidelines for the treatment of peripheral arterial disease (P...
Chronic arterial insufficiency of the lower limbs is characterized by intermittent claudication ofte...
Atherosclerosis affects large elastic and muscular arteries, the most commonly and severely affected...
The mainstay of therapy for peripheral arterial disease (PAD) consists ofatherosclerotic risk-factor...
Atherosclerosis of the lower limb arteries is the cause of ischemia in their area. Improper supply ...
Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an increasing ...
Intermittent claudication, according to the Fontaine Classification Scale is a symptom of 2nd degree...
Percutaneous intervention for peripheral artery disease hasevolved from balloon angioplasty for simp...
The treatment of intermittent claudication by physical re-training of a patient with lower limb arte...
Endovascular treatments of peripheral artery disease: revascularization techniques for patients pres...
Intermittent claudication is an expression of arteriosclerosis, in which pain occurs in the legs dur...
Peripheral arterial disease (PAD) comprises those entities which result in obstruction to blood flow...
A therosclerosis is the cause of the vast majority of cases ^*-of chronic peripheral arterial occlus...
For patients with ischemic limb loss, the treatment of choice is revascularization with the aim of s...
Luigi Uccioli,1 Marco Meloni,1 Valentina Izzo,1 Laura Giurato,1 Stefano Merolla,2 Roberto Gandini2 1...
Recommendations stated in the TASC II guidelines for the treatment of peripheral arterial disease (P...